Johnson Booster 85% Effective Against Omicron: South Africa Study

The New Diplomat
Writer

Ad

What weapons China put on display at its military parade

Chinese President Xi Jinping oversaw a massed military parade in central Beijing on Wednesday to mark the 80th anniversary of the end of World War Two. Here are some of the weapons China's People's Liberation Army put on rare public display in a show of its growing prowess and ability to project power far from…

Trump accuses Xi of conspiring against US with Putin and Kim

US President Donald Trump has accused Chinese counterpart Xi Jinping of conspiring against the US with the leaders of Russia and North Korea. Trump's comments came as China hosted world leaders at its largest-ever Victory Day parade in Beijing on Wednesday - a showcase of China's military might. In a post on Truth Social, Trump…

Oil Prices Hold Steady After U.S. Sanctions on Iranian Crude Scheme

Crude oil prices stabilized today after inching up on Tuesday following the news of new U.S. sanctions on people involved in exporting Iranian crude disguised as Iraqi crude. At the time of writing, Brent crude was trading at $68.93 per barrel and West Texas Intermediate was trading at $65.42 per barrel, both slightly down from opening. On Tuesday, the…

Ad

AFP — A booster of US coronavirus vaccine Johnson & Johnson was 85 percent effective in preventing serious illness in areas where Omicron was dominant, a South African trial study indicated Thursday.

The South African Medical Research Council conducted the study on health workers from November 15 to December 20, but it has still not been peer-reviewed.

It found the top-up jab to largely protect staff in a country where the highly transmissible strain is now behind most Covid cases.

“Data from the… study confirm that the Johnson & Johnson COVID-19 booster shot provides 85 percent effectiveness against hospitalization in areas where Omicron is dominant,” Johnson & Johnson said.

“This adds to our growing body of evidence which shows that the effectiveness of the Johnson & Johnson Covid-19 vaccine remains strong and stable over time, including against circulating variants such as Omicron and Delta,” it said.

Around half a million South African health staff have received Johnson jabs as part of clinical trials.

Africa’s hardest-hit country, South Africa has recorded more than 3.4 million cases and 90,000 deaths since the start of the pandemic.

An earlier South African study in December found the Pfizer/BioNTech vaccine to be less effective overall against Omicron, but still prevented hospital admissions by up to 70 percent.

Ad

X whatsapp